Robert F Storey Selected Research

Ticagrelor

4/2022	Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.
1/2022	Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial.
10/2021	Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study.
6/2021	Ticagrelor: clinical development and future potential.
1/2021	Novel approaches to P2Y12 inhibition and aspirin dosing.
1/2021	Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
1/2021	Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease.
1/2021	Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
1/2021	Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
1/2021	Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert F Storey Research Topics

Disease

126	Acute Coronary Syndrome 07/2022 - 09/2002
91	Myocardial Infarction 06/2022 - 11/2007
81	Hemorrhage 12/2022 - 11/2007
69	Thrombosis (Thrombus) 01/2022 - 03/2005
56	Stroke (Strokes) 01/2021 - 09/2009
31	ST Elevation Myocardial Infarction 06/2022 - 11/2007
26	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 11/2007
12	Diabetes Mellitus 01/2021 - 10/2010
12	Atrial Fibrillation 01/2021 - 09/2014
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2010
9	Inflammation (Inflammations) 06/2022 - 04/2010
7	Dyspnea (Shortness of Breath) 01/2020 - 07/2010
7	Heart Failure 01/2019 - 12/2011
7	Vascular Diseases (Vascular Disease) 11/2018 - 08/2010
6	Peripheral Arterial Disease 06/2021 - 06/2015
6	Atherosclerosis 01/2020 - 10/2005
5	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2016
5	Chronic Renal Insufficiency 01/2019 - 09/2010
5	Ischemia 01/2018 - 01/2012
5	Atherosclerotic Plaque (Atheroma) 08/2017 - 04/2010
5	Infections 08/2015 - 10/2012
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2022 - 01/2012
4	Type 2 Diabetes Mellitus (MODY) 05/2020 - 01/2017
4	Heart Diseases (Heart Disease) 12/2016 - 09/2002
3	Chest Pain (Chest Pains) 01/2022 - 04/2019
3	Ischemic Stroke 06/2021 - 09/2016
3	Sepsis (Septicemia) 01/2021 - 01/2014
3	Cardiac Arrhythmias (Arrythmia) 02/2019 - 10/2012
3	Sudden Death 11/2018 - 10/2012
3	Transient Ischemic Attack 09/2014 - 06/2012
2	Necrosis 06/2022 - 08/2015
2	COVID-19 01/2022 - 11/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2021
2	Cardiogenic Shock 01/2021 - 05/2013
2	Anemia 01/2021 - 04/2017
2	Endotoxemia 01/2021 - 04/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 10/2015
2	Hypertension (High Blood Pressure) 01/2020 - 09/2014
2	AIDS-Related Complex (ARC) 01/2020 - 08/2015
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 12/2018
2	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 12/2018
2	Bradycardia 01/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

127	TicagrelorIBA 04/2022 - 11/2007
76	Clopidogrel (Plavix)FDA Link 04/2022 - 09/2002
57	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 11/2007
21	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2010
12	Prasugrel Hydrochloride FDA Link 01/2021 - 06/2010
12	Purinergic P2Y Receptor AntagonistsIBA 04/2019 - 11/2002
10	Growth Differentiation Factor 15IBA 06/2022 - 01/2014
10	Pharmaceutical PreparationsIBA 01/2021 - 07/2010
9	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 01/2016
9	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 01/2014
9	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 07/2010
8	Troponin T (Troponin T1)IBA 06/2022 - 04/2016
8	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2016
7	C-Reactive ProteinIBA 06/2022 - 04/2010
7	FibrinIBA 01/2021 - 04/2010
7	Cystatin CIBA 12/2019 - 01/2012
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 06/2008
6	TroponinIBA 07/2022 - 05/2016
6	Cytochrome P-450 CYP2C19IBA 01/2021 - 10/2010
6	AnticoagulantsIBA 01/2021 - 06/2008
6	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 01/2012
6	vorapaxarIBA 01/2018 - 01/2012
5	Vitamin K FDA Link 01/2021 - 04/2016
5	Adenosine (Adenocard)FDA LinkGeneric 10/2020 - 08/2015
4	Trinitrotoluene (TNT)IBA 06/2022 - 01/2014
4	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2017
4	apixabanIBA 01/2021 - 04/2016
4	MicroRNAs (MicroRNA)IBA 04/2020 - 09/2013
4	LipidsIBA 01/2020 - 08/2010
4	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2016
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 09/2013
4	Adenosine Diphosphate (ADP)IBA 04/2019 - 04/2010
4	cangrelorIBA 09/2016 - 09/2002
4	CreatinineIBA 09/2013 - 09/2010
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
3	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 06/2008
3	EndotoxinsIBA 01/2021 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 12/2018
3	RivaroxabanIBA 10/2019 - 04/2016
3	AR C124910XXIBA 05/2017 - 08/2015
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 06/2022 - 07/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 05/2021 - 07/2018
2	Opiate AlkaloidsIBA 05/2021 - 07/2018
2	saxagliptin FDA Link 01/2021 - 01/2021
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2018
2	CholesterolIBA 11/2020 - 01/2020
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 09/2015
2	Interleukin-18 (Interleukin 18)IBA 12/2019 - 06/2015
2	LigandsIBA 11/2019 - 05/2011
2	Platelet Membrane Glycoprotein IIbIBA 04/2019 - 02/2016
2	Tirofiban (Aggrastat)FDA Link 07/2018 - 06/2006

Therapy/Procedure

63	Therapeutics 07/2022 - 04/2009
43	Percutaneous Coronary Intervention 06/2022 - 06/2010
40	Stents 05/2021 - 11/2002
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2021 - 09/2009
12	Secondary Prevention 01/2021 - 12/2011
2	Duration of Therapy 06/2021 - 09/2015